Clinical trial
Combating Related Epidemics in HCV Through Simplified Testing and Treatment. A Cluster Randomized Trial of Point-of-care Hepatitis C Testing and Treatment Among Key Populations
NCT07560046 is registered in ClinicalTrials.gov with Duke University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Combating Related Epidemics in HCV Through Simplified Testing and Treatment. A Cluster Randomized Trial of Point-of-care Hepatitis C Testing and Treatment Among Key Populations
- Lead sponsor
- Duke University
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- August 1, 2026
- Completion date
- December 30, 2030
- Enrollment
- 1,280 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
hepatitis b virus (hbv), hepatitis c (hcv), hiv - human immunodeficiency virus